English
| dc.contributor.author | Türkkani, G | |
| dc.contributor.author | Güngör, B | |
| dc.contributor.author | Cetin, O | |
| dc.contributor.author | Içhedef, Ç | |
| dc.contributor.author | Parlak, Y | |
| dc.contributor.author | Gümüser, FG | |
| dc.contributor.author | Bilgin, BES | |
| dc.contributor.author | Teksöz, S | |
| dc.date.accessioned | 2024-07-18T11:56:58Z | |
| dc.date.available | 2024-07-18T11:56:58Z | |
| dc.description.abstract | SPRINGER | |
| dc.identifier.issn | 1588-2780 | |
| dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/6896 | |
| dc.language.iso | Article | |
| dc.publisher | 0236-5731 | |
| dc.subject | In this study, it is aimed to design a smart drug delivery system for the diagnosis and treatment of cancer cells. Magnetic-solid lipid nanoparticles were synthesized as a drug delivery system and azathioprine (AZA) was loaded into this system. This newly created system was radiolabeled using technetium-99 m with a radiolabeling yield of 90.3%. Drug loading into the SLMNP was found as 86%. The biological behavior of Tc-99m and radiolabeled magnetic solid lipid nanoparticles loaded with azathioprine (Tc-99m-AZA-SLMNP) was investigated in vitro and in vivo. | |
| dc.title | English | |
| dc.type | DELIVERY |